119 related articles for article (PubMed ID: 1703828)
1. [Use of blood components in 30 liver transplantations at the Hamburg Eppendorf University Clinic 1984 to 1989].
Winkler M; Kühnl P; Kremer B; Henne-Bruns D; Lang T
Beitr Infusionsther; 1990; 26():194-6. PubMed ID: 1703828
[TBL] [Abstract][Full Text] [Related]
2. The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
Kaido T; Takada Y; Egawa H; Uemoto S
Hepatogastroenterology; 2009; 56(91-92):808-12. PubMed ID: 19621707
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative plasma exchange in treatment of plasma-related coagulation disorders before liver transplantation].
Hackl W; Zadrobilek E; Mauritz W; Längle F; Höcker P; Sporn P
Anaesthesist; 1989 Oct; 38(10):539-43. PubMed ID: 2556059
[TBL] [Abstract][Full Text] [Related]
4. Coagulation defects do not predict blood product requirements during liver transplantation.
Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
[TBL] [Abstract][Full Text] [Related]
5. [Problems of blood replacement in liver transplantation].
Sporn P; Mauritz W; Schindler I; Zadrobilek E; Höcker P; Piza F; Funovics J; Fritsch A
Infusionsther Klin Ernahr; 1985 Aug; 12(4):187-91. PubMed ID: 3905605
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation?
Bismuth H; Chiche L; Adam R; Castaing D
Transplant Proc; 1993 Feb; 25(1 Pt 2):1066-7. PubMed ID: 8382848
[No Abstract] [Full Text] [Related]
7. MELD score and blood product requirements during liver transplantation: no link.
Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
[TBL] [Abstract][Full Text] [Related]
8. Predictors of blood product use in orthotopic liver transplantation using the piggyback hepatectomy technique.
Mangus RS; Kinsella SB; Nobari MM; Fridell JA; Vianna RM; Ward ES; Nobari R; Tector AJ
Transplant Proc; 2007 Dec; 39(10):3207-13. PubMed ID: 18089355
[TBL] [Abstract][Full Text] [Related]
9. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence?
Muscari F; Suc B; Vigouroux D; Duffas JP; Migueres I; Mathieu A; Lavayssiere L; Rostaing L; Fourtanier G
Transpl Int; 2005 Nov; 18(11):1236-9. PubMed ID: 16221153
[TBL] [Abstract][Full Text] [Related]
10. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin reduces the need for blood products during liver transplantation.
Scudamore CH; Randall TE; Jewesson PJ; Shackleton CR; Salvian AJ; Fagan M; Frighetto L; Growe GH; Scarth I; Erb SR
Am J Surg; 1995 May; 169(5):546-9. PubMed ID: 7538269
[TBL] [Abstract][Full Text] [Related]
12. Split liver transplantation for hepatocellular carcinoma.
Sotiropoulos GC; Lang H; Frühauf NR; Molmenti EP; Omar OS; Radtke A; Paul A; Nadalin S; Frilling A; Broelsch CE; Malagò M
Hepatogastroenterology; 2006; 53(71):764-7. PubMed ID: 17086884
[TBL] [Abstract][Full Text] [Related]
13. Impact of fresh frozen plasma on hepatectomy for hepatocellular carcinoma.
Kaibori M; Saito T; Matsui K; Yamaoka M; Kamiyama Y
Anticancer Res; 2008; 28(3B):1749-55. PubMed ID: 18630454
[TBL] [Abstract][Full Text] [Related]
14. Hepatic resection or orthotopic liver transplant in cirrhotic patients with small hepatocellular carcinoma.
Vargas V; Castells L; Balsells J; Charco R; González A; Margarit C; Esteban R; Guardia J
Transplant Proc; 1995 Feb; 27(1):1243-4. PubMed ID: 7878866
[No Abstract] [Full Text] [Related]
15. [Blood component therapy (author's transl)].
Kretschmer V
Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
[TBL] [Abstract][Full Text] [Related]
16. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
[TBL] [Abstract][Full Text] [Related]
17. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations.
Massicotte L; Lenis S; Thibeault L; Sassine MP; Seal RF; Roy A
Liver Transpl; 2006 Jan; 12(1):117-23. PubMed ID: 16382461
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience.
Maluf DG; Stravitz RT; Williams B; Cotterell AH; Mas VR; Heuman D; Luketic V; Shiffman ML; Sterling R; Posner MP; Fisher RA
Transplant Proc; 2007; 39(1):153-9. PubMed ID: 17275495
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
[TBL] [Abstract][Full Text] [Related]
20. Trends in the utilization of blood components in San Pablo Hospital; 1991-1996.
Hunter Mellado R
Bol Asoc Med P R; 1997; 89(1-3):4-8. PubMed ID: 9168628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
